ADESSO SE (ADN1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ADN1 - DE000A0Z23Q5 - Common Stock
89 EUR
-1.3 (-1.44%)
ADN1 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 76 industry peers in the IT Services industry. Both the profitability and the financial health of ADN1 get a neutral evaluation. Nothing too spectacular is happening here. ADN1 is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- In the past year ADN1 was profitable.
- ADN1 had a positive operating cash flow in the past year.
- In the past 5 years ADN1 has always been profitable.
- Each year in the past 5 years ADN1 had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of 2.45%, ADN1 is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
- ADN1 has a Return On Equity of 10.90%. This is comparable to the rest of the industry: ADN1 outperforms 48.68% of its industry peers.
- ADN1's Return On Invested Capital of 5.23% is on the low side compared to the rest of the industry. ADN1 is outperformed by 64.47% of its industry peers.
- ADN1 had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 25.98%.
- The last Return On Invested Capital (5.23%) for ADN1 is above the 3 year average (3.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROIC | 5.23% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
1.3 Margins
- With a Profit Margin value of 0.99%, ADN1 is not doing good in the industry: 67.11% of the companies in the same industry are doing better.
- In the last couple of years the Profit Margin of ADN1 has declined.
- The Operating Margin of ADN1 (2.96%) is worse than 67.11% of its industry peers.
- In the last couple of years the Operating Margin of ADN1 has declined.
- ADN1 has a better Gross Margin (85.30%) than 77.63% of its industry peers.
- In the last couple of years the Gross Margin of ADN1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% |
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ADN1 is destroying value.
- Compared to 1 year ago, ADN1 has less shares outstanding
- ADN1 has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ADN1 has an improved debt to assets ratio.
2.2 Solvency
- ADN1 has an Altman-Z score of 3.63. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of ADN1 (3.63) is better than 75.00% of its industry peers.
- The Debt to FCF ratio of ADN1 is 7.88, which is on the high side as it means it would take ADN1, 7.88 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 7.88, ADN1 is not doing good in the industry: 65.79% of the companies in the same industry are doing better.
- ADN1 has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.60, ADN1 is doing worse than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Altman-Z | 3.63 |
ROIC/WACC0.94
WACC5.56%
2.3 Liquidity
- ADN1 has a Current Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
- ADN1 has a Current ratio (1.30) which is comparable to the rest of the industry.
- ADN1 has a Quick Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ADN1 (1.30) is better than 60.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 200.98% over the past year.
- ADN1 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.02% yearly.
- ADN1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.60%.
- Measured over the past years, ADN1 shows a very strong growth in Revenue. The Revenue has been growing by 23.60% on average per year.
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
3.2 Future
- The Earnings Per Share is expected to grow by 39.34% on average over the next years. This is a very strong growth
- ADN1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.28% yearly.
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.34%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.28%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 27.90 indicates a quite expensive valuation of ADN1.
- Compared to the rest of the industry, the Price/Earnings ratio of ADN1 is on the same level as its industry peers.
- When comparing the Price/Earnings ratio of ADN1 to the average of the S&P500 Index (27.38), we can say ADN1 is valued inline with the index average.
- The Price/Forward Earnings ratio is 15.74, which indicates a correct valuation of ADN1.
- Based on the Price/Forward Earnings ratio, ADN1 is valued a bit cheaper than 60.53% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, ADN1 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.9 | ||
| Fwd PE | 15.74 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADN1 indicates a somewhat cheap valuation: ADN1 is cheaper than 71.05% of the companies listed in the same industry.
- ADN1's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ADN1 is cheaper than 67.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.43 | ||
| EV/EBITDA | 6.63 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ADN1's earnings are expected to grow with 63.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y76.08%
EPS Next 3Y63.28%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.83%, ADN1 is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 2.10, ADN1 has a dividend in line with its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.85, ADN1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
5.2 History
- The dividend of ADN1 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years5
Div Non Decr Years6
5.3 Sustainability
- 31.75% of the earnings are spent on dividend by ADN1. This is a low number and sustainable payout ratio.
- ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.75%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
FRA:ADN1 (1/16/2026, 7:00:00 PM)
89
-1.3 (-1.44%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-12 2025-11-12
Earnings (Next)03-31 2026-03-31/amc
Inst Owners20.34%
Inst Owner ChangeN/A
Ins Owners50.28%
Ins Owner ChangeN/A
Market Cap581.17M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts83.33
Price Target130.39 (46.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)2.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.9 | ||
| Fwd PE | 15.74 | ||
| P/S | 0.28 | ||
| P/FCF | 12.43 | ||
| P/OCF | 7.48 | ||
| P/B | 3.04 | ||
| P/tB | 11.48 | ||
| EV/EBITDA | 6.63 |
EPS(TTM)3.19
EY3.58%
EPS(NY)5.65
Fwd EY6.35%
FCF(TTM)7.16
FCFY8.04%
OCF(TTM)11.9
OCFY13.37%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.33
PEG (5Y)N/A
Graham Number45.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROCE | 11.91% | ||
| ROIC | 5.23% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 8.22% | ||
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% | ||
| FCFM | 2.22% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Debt/EBITDA | 2.26 | ||
| Cap/Depr | 42.37% | ||
| Cap/Sales | 1.47% | ||
| Interest Coverage | 5.03 | ||
| Cash Conversion | 57.42% | ||
| Profit Quality | 224.33% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 3.63 |
F-Score7
WACC5.56%
ROIC/WACC0.94
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.34%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.28%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year304.77%
EBIT Next 3Y78.82%
EBIT Next 5Y44.13%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%
ADESSO SE / ADN1.DE FAQ
What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.
Can you provide the valuation status for ADESSO SE?
ChartMill assigns a valuation rating of 5 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.
What is the profitability of ADN1 stock?
ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ADESSO SE (ADN1.DE) stock?
The Price/Earnings (PE) ratio for ADESSO SE (ADN1.DE) is 27.9 and the Price/Book (PB) ratio is 3.04.
Can you provide the expected EPS growth for ADN1 stock?
The Earnings per Share (EPS) of ADESSO SE (ADN1.DE) is expected to grow by 83.56% in the next year.